Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes (Q73012008)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

Torben Villmow

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Bettina Kemkes-Matthes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Axel C Matzdorff

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

139-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Circulating activated platelets in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Correlation of GP53 and P-selectin expression in myeloproliferative disorders and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Increased platelet surface expression of P-selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Polymorphonuclear leukocytes in ischemic vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Formation of platelet-leukocyte conjugates in whole blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Myeloproliferative disorders: complications, survival and causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Concept of hypercoagulability: a review of its development, clinical application, and recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Increased neutrophil-platelet adhesion in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

Thrombosis and bleeding in myeloproliferative disorders: identification of at-risk patients with whole blood platelet aggregation studies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

A cell-based model of hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900354-7

7 January 2021

10.1016/S0049-3848(02)00354-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12590950%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference